INSIGHTS ON CLINICAL TRIAL DESIGN
-
![getty-155277133-storytelling-data-paper-digital]( "Real-World Value Realized From DHTs In Clinical Trials")
Real-World Value Realized From DHTs In Clinical TrialsExplore four real-world examples of clinical trials that successfully integrated DHTs. Each case study highlights how DHTs impacted specific aspects of trial design.
-
![patient recruitment iStock-1299220556]( "Outsourcing Patient Recruitment: What You Need To Know")
Outsourcing Patient Recruitment: What You Need To KnowSponsors and CROs are increasingly outsourcing patient recruitment to specialized vendors to address the ongoing challenge of meeting initial recruitment targets on time.
-
![GettyImages-1433100886 budgeting]( "Clinical Trial Budgeting Faces Pressure To Modernize")
Clinical Trial Budgeting Faces Pressure To ModernizeOutdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.
-
![GettyImages-2223908587-doctor-patient]( "Developing Community-Based And Trial-Naïve Sites: The Real ROI")
Developing Community-Based And Trial-Naïve Sites: The Real ROITrial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.
-
Recruitment Readiness: From The Front Lines To First-In-Patient4/10/2025
Operating within local markets, LES professionals conduct meticulous eligibility assessments, manage referrals, and facilitate patient navigation, ensuring a seamless pre-screening experience.
-
Antibody-Drug Conjugates: 'Magic Bullets' Become Reality2/19/2025
Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.
-
Bring RTSM In A Protocol Synopsis: Here's Why3/25/2026
Learn how early feedback from experienced teams can reveal hidden protocol and logistical risks, helping sponsors refine decisions and avoid avoidable challenges long before the final protocol is set.
-
Beyond The Database: Reaching Real Patients In Real Communities5/14/2025
There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.
-
Recruiting & Retaining More Patients Per Site:3/14/2025
Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-2161842577-business-professional-laptop-office-table]( "Overcome Biosafety Challenges With An Innovative IBC")
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
-
![GettyImages-639668490 patient]( "Scout: Beyond The Numbers")
Patient retention has benefits beyond what’s reflected in a data set. Explore some of the ways clinical trial participation can have a transformative impact on patients and their families.
-
![iStock-493302504-scientist-lab-development]( "Pre-Formulation And Material Sciences")
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
![GettyImages-1388184871-quality-compliance-approval]( "Reviewing Protocols Across Therapeutic Areas")
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
-
![GettyImages-1358835459-computer-gear-digital-hands]( "Elosity: Next-Generation RTSM")
With its agile, user-centric approach, Elosity empowers sponsors, sites, and operational teams to manage clinical programs on their terms while meeting the demands of modern clinical research.
